Form DBPR-DDC-230 Application for Product Registration - Repackaged Rx Drugs (Main & Identical) - Florida

What Is Form DBPR-DDC-230?

This is a legal form that was released by the Florida Department of Business & Professional Regulation - a government authority operating within Florida. As of today, no separate filing guidelines for the form are provided by the issuing department.

FAQ

Q: What is the DBPR-DDC-230 form?
A: The DBPR-DDC-230 form is an application for product registration for repackaged prescription drugs (both main and identical) in the state of Florida.

Q: What is the purpose of the DBPR-DDC-230 form?
A: The purpose of the DBPR-DDC-230 form is to register repackaged prescription drugs in Florida.

Q: Who needs to submit the DBPR-DDC-230 form?
A: Any entity or individual that repackages prescription drugs in Florida needs to submit the DBPR-DDC-230 form.

Q: What information is required on the DBPR-DDC-230 form?
A: The DBPR-DDC-230 form requires information about the repackaged drugs, including the manufacturer, lot numbers, and expiration dates.

Q: Are there any fees associated with the DBPR-DDC-230 form?
A: Yes, there are fees associated with the DBPR-DDC-230 form. The exact amount depends on the number of products being registered.

Q: Is it mandatory to submit the DBPR-DDC-230 form?
A: Yes, it is mandatory to submit the DBPR-DDC-230 form if you are repackaging prescription drugs in Florida.

Q: What are the consequences of not submitting the DBPR-DDC-230 form?
A: Failure to submit the DBPR-DDC-230 form can result in penalties and legal consequences.

Q: Is there a deadline for submitting the DBPR-DDC-230 form?
A: There is no specific deadline mentioned for submitting the DBPR-DDC-230 form. However, it should be submitted before you start repackaging prescription drugs.